PE20090718A1 - Derivados de espiroindolinona - Google Patents
Derivados de espiroindolinonaInfo
- Publication number
- PE20090718A1 PE20090718A1 PE2008000875A PE2008000875A PE20090718A1 PE 20090718 A1 PE20090718 A1 PE 20090718A1 PE 2008000875 A PE2008000875 A PE 2008000875A PE 2008000875 A PE2008000875 A PE 2008000875A PE 20090718 A1 PE20090718 A1 PE 20090718A1
- Authority
- PE
- Peru
- Prior art keywords
- diona
- tetrahydrospiro
- indol
- chlorophenyl
- triazine
- Prior art date
Links
- -1 3-CHLOROPHENYL Chemical class 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 3
- FYADHXFMURLYQI-UHFFFAOYSA-N 1,2,4-triazine Chemical compound C1=CN=NC=N1 FYADHXFMURLYQI-UHFFFAOYSA-N 0.000 abstract 1
- CHRWXDFANNGYCB-UHFFFAOYSA-N 2h-pyrido[2,1-c][1,2,4]triazine Chemical compound C1=CC=CC2=NNC=CN21 CHRWXDFANNGYCB-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
REFERIDA A UN COMPUESTO DE FORMULA I, DONDE X ES H, HALOGENO, CIANO, ENTRE OTROS; R1, R2, R3 Y R4 SON CADA UNO ALQUILO INFERIOR, ALQUENILO INFERIOR, ARILO, ENTRE OTROS; R ES H, ALQUILO INFERIOR SUSTITUIDO O NO. SON COMPUESTOS PREFERIDOS: (6'R,3R,8'S)-6-CLORO-8'-(3-CLOROFENIL)-6'-(5-FLUOR-2-METILFENIL)-2'-METIL-6',7',8',9'-TETRAHIDROESPIRO[3H-INDOL-3,7'-(2H-PIRIDO[2,1-c][1,2,4]TRIAZINA)]-2,3'(1H)-DIONA, (6'R,3R,8'S)-6-CLORO-8'-(3-CLOROFENIL)-2'-(3-DIMETILAMINO-PROPIL)-6'-(1-METILENO-PROPIL)-6', 7',8',9'-TETRAHIDROESPIRO-[3H-INDOL-3,7'-(2H-PIRIDO[2,1-c][1,2,4]TRIAZINA)-2,3'(1H)-DIONA; ENTRE OTROS. TAMBIEN SE REFIERE A UNA FORMULACION PARA UNA SOLA UNIDAD DE DOSIFICACION ORAL. DICHOS COMPUESTOS TIENEN ACTIVIDAD INHIBIDORA DE LA INTERACCION MDM2-p53 Y SON UTILES EN EL TRATAMIENTO DE TRANSTORNOS DE PROLIFERACION CELULAR COMO EL CANCER
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93136807P | 2007-05-23 | 2007-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20090718A1 true PE20090718A1 (es) | 2009-06-20 |
Family
ID=39645560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008000875A PE20090718A1 (es) | 2007-05-23 | 2008-05-21 | Derivados de espiroindolinona |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7834179B2 (es) |
| EP (1) | EP2152714B1 (es) |
| JP (1) | JP2010527954A (es) |
| KR (1) | KR20090130319A (es) |
| CN (1) | CN101679448A (es) |
| AR (1) | AR066659A1 (es) |
| AT (1) | ATE549340T1 (es) |
| AU (1) | AU2008253117A1 (es) |
| BR (1) | BRPI0812155A2 (es) |
| CA (1) | CA2687160A1 (es) |
| ES (1) | ES2382139T3 (es) |
| IL (1) | IL202020A0 (es) |
| MX (1) | MX2009012595A (es) |
| PE (1) | PE20090718A1 (es) |
| TW (1) | TW200901994A (es) |
| WO (1) | WO2008141975A1 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776875B2 (en) * | 2007-12-19 | 2010-08-17 | Hoffman-La Roche Inc. | Spiroindolinone derivatives |
| US7723372B2 (en) | 2008-03-19 | 2010-05-25 | Hoffman-La Roche Inc. | Spiroindolinone derivatives |
| US8217051B2 (en) * | 2009-02-17 | 2012-07-10 | Hoffmann-La Roche Inc. | Spiroindolinone derivatives |
| AU2010319595B2 (en) * | 2009-11-12 | 2015-09-17 | The Regents Of The University Of Michigan | Spiro-oxindole MDM2 antagonists |
| JO2998B1 (ar) * | 2010-06-04 | 2016-09-05 | Amgen Inc | مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان |
| FR2967072B1 (fr) | 2010-11-05 | 2013-03-29 | Univ Dundee | Procede pour ameliorer la production de virus et semences vaccinales influenza |
| CN103298818B (zh) | 2010-11-12 | 2016-06-29 | 密歇根大学董事会 | 螺-吲哚酮mdm2拮抗剂 |
| WO2012121361A1 (ja) | 2011-03-10 | 2012-09-13 | 第一三共株式会社 | ジスピロピロリジン誘導体 |
| KR101688268B1 (ko) | 2011-05-11 | 2016-12-20 | 더 리젠츠 오브 더 유니버시티 오브 미시간 | 스피로-옥신돌 mdm2 길항물질 |
| EP2760845B1 (en) | 2011-09-27 | 2016-11-16 | Amgen Inc. | Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer |
| TWI586668B (zh) | 2012-09-06 | 2017-06-11 | 第一三共股份有限公司 | 二螺吡咯啶衍生物之結晶 |
| WO2014089904A1 (en) | 2012-12-10 | 2014-06-19 | Abbvie Inc. | Triazinone compounds |
| CA2895504A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
| US11407721B2 (en) | 2013-02-19 | 2022-08-09 | Amgen Inc. | CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer |
| AU2014223547B2 (en) | 2013-02-28 | 2017-11-16 | Amgen Inc. | A benzoic acid derivative MDM2 inhibitor for the treatment of cancer |
| JP6377123B2 (ja) | 2013-03-14 | 2018-08-22 | アムジエン・インコーポレーテツド | 癌の治療のためのｍｄｍ２阻害剤としてのヘテロアリール酸モルホリノン化合物 |
| JOP20200296A1 (ar) | 2013-06-10 | 2017-06-16 | Amgen Inc | عمليات صنع وأشكال بلورية من mdm2 مثبط |
| CN103435621B (zh) * | 2013-07-26 | 2015-11-04 | 中国林业科学研究院林产化学工业研究所 | 螺环喹唑啉衍生物及其制备方法 |
| JP6503386B2 (ja) | 2014-07-03 | 2019-04-17 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ＭＤＭ２−ｐ５３阻害剤としての新しいスピロ［３Ｈ−インドール−３，２’−ピロリジン］−２（１Ｈ）−オン化合物および誘導体 |
| ES2968789T3 (es) | 2015-02-20 | 2024-05-14 | Daiichi Sankyo Co Ltd | Procedimiento combinado para el tratamiento del cáncer |
| US10485794B2 (en) | 2015-04-13 | 2019-11-26 | Daiichi Sankyo Company, Limited | Treatment method by combined use of MDM2 inhibitor and BTK inhibitor |
| JP6602470B2 (ja) | 2015-10-09 | 2019-11-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｍｄｍ２−ｐ５３阻害薬としてのスピロ［３ｈ−インドール−３，２‘−ピロリジン］−２（１ｈ）−オン化合物及び誘導体 |
| ES2858151T3 (es) | 2016-05-20 | 2021-09-29 | Hoffmann La Roche | Conjugados de PROTAC-anticuerpo y procedimientos de uso |
| KR20190068544A (ko) | 2016-10-17 | 2019-06-18 | 다이이찌 산쿄 가부시키가이샤 | Mdm2 저해제와 dna 메틸트랜스페라아제 저해제의 병용 치료법 |
| EP3511334A1 (en) * | 2018-01-16 | 2019-07-17 | Adamed sp. z o.o. | 1,2,3',5'-tetrahydro-2'h-spiro[indole-3,1'-pyrrolo[3,4-c]pyrrole]-2,3'-dione compounds as therapeutic agents activating tp53 |
| WO2023056069A1 (en) | 2021-09-30 | 2023-04-06 | Angiex, Inc. | Degrader-antibody conjugates and methods of using same |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2598690C (en) * | 2005-02-22 | 2011-11-15 | The Regents Of The University Of Michigan | Small molecule inhibitors of mdm2 and uses thereof |
| EP1911753A1 (en) * | 2005-07-29 | 2008-04-16 | Takeda Pharmaceutical Company Limited | Spiro-cyclic compound |
-
2008
- 2008-04-11 US US12/101,206 patent/US7834179B2/en not_active Expired - Fee Related
- 2008-05-13 WO PCT/EP2008/055831 patent/WO2008141975A1/en active Application Filing
- 2008-05-13 KR KR1020097024251A patent/KR20090130319A/ko active IP Right Grant
- 2008-05-13 MX MX2009012595A patent/MX2009012595A/es active IP Right Grant
- 2008-05-13 AT AT08759539T patent/ATE549340T1/de active
- 2008-05-13 CN CN200880016685A patent/CN101679448A/zh active Pending
- 2008-05-13 EP EP08759539A patent/EP2152714B1/en not_active Not-in-force
- 2008-05-13 CA CA002687160A patent/CA2687160A1/en not_active Abandoned
- 2008-05-13 ES ES08759539T patent/ES2382139T3/es active Active
- 2008-05-13 BR BRPI0812155A patent/BRPI0812155A2/pt not_active IP Right Cessation
- 2008-05-13 JP JP2010508795A patent/JP2010527954A/ja active Pending
- 2008-05-13 AU AU2008253117A patent/AU2008253117A1/en not_active Abandoned
- 2008-05-20 TW TW097118529A patent/TW200901994A/zh unknown
- 2008-05-21 AR ARP080102149A patent/AR066659A1/es unknown
- 2008-05-21 PE PE2008000875A patent/PE20090718A1/es not_active Application Discontinuation
-
2009
- 2009-11-09 IL IL202020A patent/IL202020A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2152714A1 (en) | 2010-02-17 |
| WO2008141975A1 (en) | 2008-11-27 |
| ATE549340T1 (de) | 2012-03-15 |
| CN101679448A (zh) | 2010-03-24 |
| CA2687160A1 (en) | 2008-11-27 |
| EP2152714B1 (en) | 2012-03-14 |
| BRPI0812155A2 (pt) | 2019-09-24 |
| KR20090130319A (ko) | 2009-12-22 |
| JP2010527954A (ja) | 2010-08-19 |
| US7834179B2 (en) | 2010-11-16 |
| ES2382139T3 (es) | 2012-06-05 |
| TW200901994A (en) | 2009-01-16 |
| US20080293723A1 (en) | 2008-11-27 |
| AU2008253117A1 (en) | 2008-11-27 |
| MX2009012595A (es) | 2009-12-07 |
| IL202020A0 (en) | 2010-06-16 |
| AR066659A1 (es) | 2009-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20090718A1 (es) | Derivados de espiroindolinona | |
| PE20060531A1 (es) | Derivados de piridazin-3-(2h)-ona como inhibidores de la fosfodiesterasa 4 | |
| PE20091095A1 (es) | Moduladores de gamma secretasa | |
| PE20081346A1 (es) | Derivados de espiroindolinona como antagonistas de mdm2 | |
| PE20080695A1 (es) | Derivados de dihidropirazolopirimidinona como inhibidores de quinasa weel | |
| PE20090279A1 (es) | Derivados de 3,3-espiroindolinona como agentes antagonistas de mdm2 | |
| PE20091466A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il-amina | |
| TW200720266A (en) | Benzodioxane and benzodioxolan derivatives and uses thereof | |
| PE20130012A1 (es) | Derivados de pirazol como inhibidores de jak | |
| PE20090835A1 (es) | Derivados de quinazolina como inhibidores de la pi3 quinasa | |
| TW200719886A (en) | Dihydrobenzofuran derivatives and uses thereof | |
| PE20070832A1 (es) | Derivados de piridazinona como inhibidores de la tirosina quinasa | |
| ES2299896T3 (es) | Derivados de benzazepina como antagonistas h3 de histamina. | |
| EA200400466A1 (ru) | Производные пиперазина с антагонистической активностью к рецептору ccr1 | |
| PE20071177A1 (es) | Derivados de 3,5-piridina como inhibidores de renina | |
| CY1113642T1 (el) | Γεφυρωμενες δικυκλικες ετεροαρυλ υποκατεστημενες τριαζολες, χρησιμες ως αναστολεις της axl | |
| PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
| PE20081845A1 (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1 | |
| BR0315547A (pt) | Derivados de quinolina como antagonistas de crth2 | |
| EA200800018A1 (ru) | Аминопиримидины в качестве модуляторов киназы | |
| PE20040647A1 (es) | Inhibidores de cinasas de tirosina | |
| MXPA05010621A (es) | Pirimidinonas sustituidas. | |
| PE20060691A1 (es) | Serinamidas sustituidas por benzoilo | |
| PE20110671A1 (es) | Derivados de diazabicicloalcanos como moduladores de la actividad de los receptores nicotinicos de la acetilcolina | |
| ECSP10010429A (es) | Derivados bicíclicos heterocíclicos o espirobicíclicos heterocíclicos enlazados, de pirazolo[1,5-a]pirimidinas, procedimientos para su preparación y usos de los mismos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |